LINC02166

Across TCGA pan-cancer cohorts, LINC02166 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC02166 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher LINC02166 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02166 expression acts as an unfavorable survival marker, although some lineages such as KIRP and HNSC show a favorable association.

KIRP, HNSC, and READ are the cancer types where LINC02166 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	All	0.982	0.855	<.001	123	view →
HNSC	OS	Tertile	II,III,IV	0.594	0.338	.001	87	view →
READ	DFS	Tertile	III,IV	0.587	0.174	<.001	71	view →
LGG	OS	Median	All	0.723	0.890	<.001	54	view →
UCEC	OS	Quartile	All	0.888	0.683	<.001	28	view →
BRCA	OS	Median	IV	0.718	0.179	.001	26	view →
THYM	DFS	Tertile	All	0.965	0.795	.004	24	view →
CHOL	OS	Tertile	All	0.892	0.184	.002	22	view →
SKCM	OS	Quartile	All	0.249	0.557	.004	19	view →
ACC	OS	Quartile	II,III,IV	0.730	0.971	.005	17	view →
CESC	OS	Tertile	All	0.924	0.820	.009	14	view →
LUAD	DFS	Median	IV	0.270	0.807	.003	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC02166–KIRP (OS)

Open the KIRP breakdown →